Academic Radiology
Volume 16, Issue 1 , Pages 71-78 , January 2009

Delta-projection Imaging on Contrast-enhanced Ultrasound to Quantify Tumor Microvasculature and Perfusion

  • Chandra M. Sehgal, PhD

      Affiliations

    • Department of Radiology, University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104
    • Corresponding Author InformationAddress correspondence to: C.M.S.
    • ,
  • Theodore W. Cary, BA

      Affiliations

    • Department of Radiology, University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104
    • ,
  • Peter H. Arger, MD

      Affiliations

    • Department of Radiology, University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104
    • ,
  • Andrew K.W. Wood, DVSc, PhD

      Affiliations

    • Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania

Received 12 June 2008 ,Accepted 2 July 2008.

References 

  1. Hinnen P, Eskens FA. Vascular disrupting agents in clinical development. Br J Cancer. 2007;96:1159–1165
  2. Lippert JW. Vascular disrupting agents. Bioorg Med Chem. 2007;15:605–615
  3. Wood AKW, Ansaloni S, Ziemer LS, Lee WMF, Feldman MD, Sehgal CM. The antivascular action of physiotherapy ultrasound on murine tumors. Ultrasound Med Biol. 2005;31:1403–1410
  4. Bunte RM, Ansaloni S, Sehgal CM, Lee WMF, Wood AKW. Histopathological observations of the antivascular effects of physiotherapy ultrasound on a murine neoplasm. Ultrasound Med Biol. 2006;32:453–461
  5. Tsai JF, Makonnen S, Feldman M, Sehgal CM, Maity A, Lee WMF. Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis. Cancer Biol Ther. 2005;4:1395–1400
  6. Chen B, Pogue BW, Luna JM, Hardman RL, Hoopes PJ, Hasan T. Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications. Clin Cancer Res. 2006;12:917–923
  7. Sehgal CM, Arger PH, Pugh CR, Kirchofer JI, Kotlar EY, Bovee KC. Comparison of power Doppler and B-scan sonography for renal imaging using a sonographic contrast agent. J Ultrasound Med. 1998;17:751–756
  8. Kamotani Y, Lee WM, Arger PH, Cary TW, Sehgal CM. Multigated contrast-enhanced power Doppler to measure blood flow in mice tumors. Ultrasound Med Biol. 2003;29:977–984
  9. Lassau N, Koscielny S, Opolon P, et al. Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol. 2001;36:50–55
  10. Iordanescu I, Becker C, Zetter B, Dunning P, Taylor GA. Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US effect of angiogenesis inhibitors. Radiology. 2002;222:460–467
  11. Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res. 2002;62:6371–6375
  12. Niermann KJ, Fleischer AC, Huamani J, et al. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. J Ultrasound Med. 2007;26:749–756
  13. Kim SH, Lee JM, Kim KG, et al. Comparison of fundamental sonography, tissue-harmonic sonography, fundamental compound sonography, and tissue-harmonic compound sonography for focal hepatic lesions. Eur Radiol. 2006;16:2444–2453
  14. Clevert D, Jung EM, Jungius KP, Ertan K, Kubale R. Value of tissue harmonic imaging (THI) and contrast harmonic imaging (CHI) in detection and characterisation of breast tumours. Eur Radiol. 2007;17:1–10
  15. Yamamoto K, Shiraki K, Nakanishi S, et al. 1.5 harmonic imaging sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma. World J Gastroenterol. 2005;11:5607–5613
  16. Forsberg F, Liu JB, Shi WT, et al. In vivo perfusion estimation using subharmonic contrast microbubble signals. J Ultrasound Med. 2006;25:15–21
  17. Wood AKW, Bunte RM, Cohen JD, Tsai JH, Lee William M-F, Sehgal CM. The antivascular action of physiotherapy ultrasound on a murine tumor: role of a microbubble contrast agent. Ultrasound Med Biol. 2007;33:1901–1910
  18. Sehgal CM, Arger PH, Rowling SE, Conant EF, Reynolds C, Patton JA. Quantitative vascularity of breast masses by Doppler imaging: regional variations and diagnostic implications. J Ultrasound Med. 2000;19:427–440
  19. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249–257
  20. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182–1186
  21. Wang Z, Tang J, An L, et al. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med. 2007;26:757–762
  22. Huber S, Helbich T, Kettenbach J, Dock W, Zuna I, Delorme S. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US—early experience. Radiology. 1998;208:485–489
  23. Perini R, Choe R, Yodh AG, Sehgal C, Divgi CR, Rosen MA. Non-invasive assessment of tumor vasculature: techniques and clinical applications. Cancer Metastasis Rev. In press.

1 This study was supported by grant EB001713 from the National Institutes of Health, Bethesda, MD.

PII: S1076-6332(08)00416-9

doi: 10.1016/j.acra.2008.07.013

Academic Radiology
Volume 16, Issue 1 , Pages 71-78 , January 2009

Article Tools

* Image Usage & Resolution